Lv5
1320 积分 2022-06-20 加入
Inflammasome protein scaffolds the DNA damage complex during tumor development
12天前
已完结
Structured Exercise after Adjuvant Chemotherapy for Colon Cancer
22天前
已完结
A cross-cultural exploration of positive and negative body image and well-being among breast cancer survivors in Australia and China
23天前
已关闭
Characterization and clinical management of adverse events following treatment with repotrectinib: a TRIDENT-1 analysis
23天前
已完结
First-line treatment patterns and real-world outcomes in patients with advanced KRAS-mutated non-small cell lung cancer with high unmet need
23天前
已完结
Real-world treatment sequencing and survival in ROS1-Rearranged NSCLC across evolving treatment eras: Findings from the AURORA multi-centre registry (AURORA-ROS1)
23天前
已完结
D3S-001 in advanced solid tumors with KRASG12C mutations: a phase 1 trial
1个月前
已完结
Amivantamab plus Lazertinib in Previously Untreated EGFR -Mutated Advanced NSCLC
1个月前
已完结
Early phase clinical trials extension to guidelines for the content of statistical analysis plans
1个月前
已关闭
Patient-reported outcomes and time to symptomatic progression from PAPILLON: amivantamab plus chemotherapy vs chemotherapy as first-line treatment of EGFR exon 20 insertion-mutated advanced NSCLC
1个月前
已完结
皖公网安备34019202002308
